Protection Role of Resveratrol Against Alcohol-Induced Heart Defect in Zebrafish Embryos

Protection Role of Resveratrol Against Alcohol-Induced Heart Defect in Zebrafish Embryos

Alcohol-induced heart defects are among the most significant clinical manifestations of fetal alcohol spectrum disorder (FASD), characterized by atrioventricular septal defects and arterial conical deformities. Resveratrol, a polyphenol component of the traditional Chinese herb Polygonum cuspidatum, is known for its beneficial effects on the cardiovascular system. It has been shown to improve heart dysfunction, myocardial hypertrophy, and pressure overload, inhibit platelet aggregation, prevent atherosclerosis, and scavenge free radicals. However, its effects on alcohol-induced heart defects during heart formation remain unexplored. Zebrafish embryos, with their transparent bodies, in vitro fertilization, and short reproductive cycles, provide an excellent model for cardiovascular research. The immersion-based alcohol delivery method used with zebrafish embryos is non-invasive, unlike most alcohol administration protocols in rodent models.

This study aimed to investigate the protective effect of resveratrol against alcohol-induced heart defects during zebrafish heart formation. Zebrafish (Danio rerio; AB strains) were raised in automatic fish housing systems at 28.5°C with a 14/10-hour light/dark schedule. Embryos were obtained from spawning adult zebrafish. Alcohol solutions (1% and 2%) were prepared from a stock solution of 95% ethanol diluted with system water. Resveratrol (0.3 g) was dissolved in 10 L of system water to obtain a saturated solution (0.03 g/L).

Within 2 hours of spawning, fertilized eggs were collected and divided into six groups (20 embryos/group) and exposed to different combinations of drugs until 3 days post-fertilization (dpf): 0 alcohol + 0 resveratrol (control group), 1% alcohol + 0 resveratrol, 2% alcohol + 0 resveratrol, 0 alcohol + resveratrol (0.03 g/L), 1% alcohol + resveratrol (0.03 g/L), and 2% alcohol + resveratrol (0.03 g/L). At 3 dpf, 10 embryos from each group were randomly selected for morphologic observation and heart rate measurement. Pericardial edema was defined as an abnormal accumulation of fluid around the heart chambers. Body length of larvae was measured using the calibrated reticule of the microscope. Heart rate was measured manually for 1 minute in each embryo. Images were digitally acquired with an inverted microscope. After measurements, embryos were collected for mRNA extraction and reverse transcription (RT) to cDNA for RT quantitative polymerase chain reaction (RT-qPCR). Three independent experiments were performed in triplicate.

At 3 dpf, total RNA was extracted from the 10 whole embryos using the TRIzol reagent. A total of 500 ng of RNA was reverse transcribed to cDNA using the PrimeScript RT reagent kit. Each real-time PCR amplification reaction was performed with 1 mL of cDNA using Power SYBR Green PCR mix and 0.5 mmol/L of each primer. Primers were synthesized by Sunny Biotechnology Co., Ltd. The detailed primer sequences were as follows: bmpr2b (Forward: 5′-GGCTCTGCTCACTGCTTCTG-3′, Reverse: 5′-TGCGATGGCGTTGTGGTAAC-3′), hand2 (Forward: 5′-GAGTTTAGTTGGAGGGTTTCCCCACC-3′, Reverse: 5′-GTAGTGCGAATGGTCGAGCCCG-3′), tbx5a (Forward: 5′-CAGACAAACAGAATGCAGCCGTCA-3′, Reverse: 5′-ACTTTGAAGCTGGGAAACATCCGC-3′), and b-actin (Forward: 5′-CGAGCTGTCTTCCCATCCA-3′, Reverse: 5′-TCACCAACGTAGCTAGCTGTCTTTCTG-3′). Thermal cycling was carried out in a LightCycler 480. b-actin was used as an internal control for normalization.

All data analyses were performed using the statistical software GraphPad Prism 7.0. Differences in body length and heart rate between alcohol and alcohol with resveratrol groups were assessed by the independent Student t-test. Gene expression data were analyzed by one-way or two-way analysis of variance. A value of P<0.05 was considered statistically significant.

Obvious pericardial edema, appearing as a large transparent bubble around the heart, was found in the alcohol-exposed groups and was more severe with 2% alcohol than with 1% alcohol. The addition of resveratrol in the 1% alcohol + resveratrol group partly alleviated the pericardial edema compared to the 1% alcohol group. However, morphology was not improved by resveratrol in embryos exposed to 2% alcohol. Differences in pericardial edema between the different groups did not reach statistical significance. Body lengths were also measured to quantify morphologic changes. Compared to untreated control embryos, alcohol-treated embryos had shorter bodies at 3 dpf. The addition of resveratrol significantly recovered body lengths in 1% (P=0.046) and 2% (P<0.001) alcohol-treated larvae.

At 3 dpf, heart rate was found to be higher in alcohol-treated groups compared to the control group. The addition of resveratrol significantly lowered heart rates in 1% alcohol-treated embryos (P=0.011) but had no significant effect on faster heart rates induced by 2% alcohol.

To further investigate the possible underlying mechanisms for resveratrol’s effect on the cardiovascular system, the mRNA expression of several heart-related genes (bmpr2a, bmpr2b, gata5, hand2, nkx2.5, tbx1, and tbx5a) was determined by RT-qPCR. Resveratrol induced significant changes in the mRNA expression of bmpr2b, hand2, and tbx5a compared to alcohol-treated groups. The other four genes showed no negative results. Regarding bmpr2a, the addition of resveratrol to alcohol-treated embryos significantly elevated its mRNA expression compared to 1% alcohol (P<0.001) and 2% alcohol (P<0.001) groups. Similarly, resveratrol treatment significantly increased hand2 mRNA expression in alcohol-treated embryos (P=0.019 and 0.003 compared to 1% and 2% alcohol groups, respectively). Regarding tbx5a, its mRNA level was increased in the 1% alcohol + resveratrol group compared to that in the 1% alcohol group, while it was slightly decreased in the 2% alcohol + resveratrol group compared to that in the 2% alcohol group.

This study demonstrated that resveratrol had a protective effect against alcohol-induced morphologic and functional abnormalities in zebrafish embryos, such as shortening of body length, pericardial edema, and tachycardia. Exposure to resveratrol was also found to alter the expression of some heart-related genes, such as bmpr2b, hand2, and tbx5a, at 3 dpf. The study provided evidence regarding the potential protective effect of Polygonum cuspidatum against FASD.

In the present study, it was demonstrated that resveratrol could protect against alcohol-induced morphologic changes. Short body lengths and pericardial edema were observed in zebrafish embryos exposed to alcohol, as shown in a previous study. Resveratrol was found to alleviate pericardial edema and tachycardia induced by 1% alcohol but had no significant effect on the same phenomena induced by 2% alcohol. This possibly means that changes induced by 2% alcohol were too severe to be recovered by resveratrol during heart formation.

Moreover, the results showed that resveratrol could alter the mRNA expression of bmpr2b, hand2, and tbx5a, which are critical transcription factors for vertebrate heart development, in alcohol + resveratrol groups compared to untreated groups exposed to the same alcohol concentrations. Alteration of these genes’ expression during the process of heart development may lead to its disturbance. The work demonstrated that the cardiovascular protective effects of resveratrol might be mediated via altering the expression of heart-related genes.

In summary, resveratrol can recover morphologic and functional abnormalities induced by alcohol to a certain extent. Resveratrol exhibited more significant protective effects against heart deformations induced by 1% alcohol compared to those induced by 2% alcohol, which means that a higher alcohol concentration can induce more severe damage that cannot be alleviated by resveratrol afterward. Analysis of heart-related gene expression provides evidence for resveratrol’s protective effects against alcohol-induced heart abnormalities. Results of this study also provide a better understanding of the protective effects of resveratrol against FASD.

doi.org/10.1097/CM9.0000000000000194

Was this helpful?

0 / 0